Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Innovations in Oral Therapies for Inflammatory Bowel Disease
Christopher Ma, Robert Battat, Parambir S. Dulai, et al.
Drugs (2019) Vol. 79, Iss. 12, pp. 1321-1335
Closed Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Pathway paradigms revealed from the genetics of inflammatory bowel disease
Daniel B. Graham, Ramnik J. Xavier
Nature (2020) Vol. 578, Iss. 7796, pp. 527-539
Open Access | Times Cited: 591
Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Xue Chen, Qinfan Yao, Xinyu Gu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 214
3D printed tacrolimus suppositories for the treatment of ulcerative colitis
Iria Seoane‐Viaño, Jun Jie Ong, Asteria Luzardo‐Álvarez, et al.
Asian Journal of Pharmaceutical Sciences (2020) Vol. 16, Iss. 1, pp. 110-119
Open Access | Times Cited: 111
A dual pH and microbiota-triggered coating (Phloral™) for fail-safe colonic drug release
Felipe Varum, Ana Cristina Freire, Hala M. Fadda, et al.
International Journal of Pharmaceutics (2020) Vol. 583, pp. 119379-119379
Open Access | Times Cited: 78
Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia
Shu‐Chen Wei, Jose D. Sollano, Yee Tak Hui, et al.
Expert Review of Gastroenterology & Hepatology (2020) Vol. 15, Iss. 3, pp. 275-289
Closed Access | Times Cited: 70
Oral pectin/oligochitosan microspheres for colon-specific controlled release of quercetin to treat inflammatory bowel disease
Shisuo Jing, Huayuan Chen, Ergang Liu, et al.
Carbohydrate Polymers (2023) Vol. 316, pp. 121025-121025
Closed Access | Times Cited: 24
Efficacy and Safety of Advanced Oral Small Molecules for Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
Virginia Solitano, Sudheer K. Vuyyuru, John K MacDonald, et al.
Journal of Crohn s and Colitis (2023) Vol. 17, Iss. 11, pp. 1800-1816
Closed Access | Times Cited: 24
OPTICORE™, an innovative and accurate colonic targeting technology
Felipe Varum, Ana Cristina Freire, Roberto Bravo, et al.
International Journal of Pharmaceutics (2020) Vol. 583, pp. 119372-119372
Open Access | Times Cited: 69
New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy
A. Teruel, Isabel González‐Álvarez, Marival Bermejo, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6502-6502
Open Access | Times Cited: 67
Targeting JAK/STAT signaling pathways in treatment of inflammatory bowel disease
Liang Wang, Yan Hu, Baohui Song, et al.
Inflammation Research (2021) Vol. 70, Iss. 7, pp. 753-764
Closed Access | Times Cited: 50
Ozanimod: A Review in Ulcerative Colitis
Julia Paik
Drugs (2022) Vol. 82, Iss. 12, pp. 1303-1313
Open Access | Times Cited: 35
Probiotic Escherichia coli Nissle 1917 Expressing Elafin Protects Against Inflammation and Restores the Gut Microbiota
Guigen Teng, Haohuan Li, Yun Liu, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 31
Safety, Pharmacokinetics, and Pharmacodynamics of Etrasimod: Single and Multiple Ascending Dose Studies in Healthy Adults
Caroline A. Lee, Stefan Schreiber, Brian Bressler, et al.
Clinical Pharmacology in Drug Development (2024) Vol. 13, Iss. 5, pp. 534-548
Open Access | Times Cited: 7
<p>Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis</p>
Jianping Deng, Zicong Wu, Zhenling Zhao, et al.
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 3937-3951
Open Access | Times Cited: 49
Vitexin prevents colitis-associated carcinogenesis in mice through regulating macrophage polarization
Yonger Chen, Bingxin Wang, Xin Yuan, et al.
Phytomedicine (2021) Vol. 83, pp. 153489-153489
Closed Access | Times Cited: 39
Effects of molecular weight of chitosan on anti-inflammatory activity and modulation of intestinal microflora in an ulcerative colitis model
Wei Niu, Yuelin Dong, Ziwei Fu, et al.
International Journal of Biological Macromolecules (2021) Vol. 193, pp. 1927-1936
Closed Access | Times Cited: 37
Novel Small Molecules in IBD: Current State and Future Perspectives
André Jefremow, Markus F. Neurath
Cells (2023) Vol. 12, Iss. 13, pp. 1730-1730
Open Access | Times Cited: 16
Repairing the intestinal mucosal barrier of traditional Chinese medicine for ulcerative colitis: a review
Yichen Zong, Jie Meng, Tangyou Mao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Alginate/silk fibroin/Zn2+ composite microspheres for site-specific delivery for enhanced ulcerative colitis therapy
Yaoyao Du, Yuting Jiang, Yijie Song, et al.
Chemical Engineering Journal (2024) Vol. 495, pp. 153441-153441
Closed Access | Times Cited: 5
User's guide to JAK inhibitors in inflammatory bowel disease
Ted A. Spiewak, Anish Patel
Current Research in Pharmacology and Drug Discovery (2022) Vol. 3, pp. 100096-100096
Open Access | Times Cited: 20
Obefazimod: A First-in-class Drug for the Treatment of Ulcerative Colitis
Séverine Vermeire, Virginia Solitano, Laurent Peyrin‐Biroulet, et al.
Journal of Crohn s and Colitis (2023) Vol. 17, Iss. 10, pp. 1689-1697
Closed Access | Times Cited: 12
Small molecules for inflammatory bowel disease and the risk of infection and malignancy: A systematic review and meta-Analysis
LiXue Chen, Chang Su, Hao Ding, et al.
Digestive and Liver Disease (2024) Vol. 56, Iss. 11, pp. 1828-1838
Closed Access | Times Cited: 4
Innovations in Drug Delivery Systems for Biologics: Enhancing Stability and Targeted Delivery for Next-Generation Therapeutics
Pushpendra Kumar, Ankit Goel, Biswajit Dash, et al.
Chinese Journal of Applied Physiology (2025), pp. e20250001-e20250001
Closed Access
An Analysis of the Effectiveness and Safety of Upadacitinib in the Treatment of Inflammatory Bowel Disease: A Multicenter Real-World Study
Hongzhen Wu, Tingting Xie, Qiao Yu, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 190-190
Open Access
Real-world prevalence of potential drug-drug interactions associated with oral advanced therapies indicated for ulcerative colitis
Maryia Zhdanava, Sabree Burbage, Todor Totev, et al.
Current Medical Research and Opinion (2025), pp. 1-23
Closed Access
Page 1 - Next Page

Scroll to top